Pioneers in the life sciences, our founders, Scott R. Magnuson, Gary M. Pusateri and Michael T. Falduto each have more than 30 years of experience in their respective field of expertise.
For the previous 13 years, Paradise founders have operated GenUs BioSystems, a leading national contract laboratory, performing over 700 independent scientific studies that have identified gene expression profiles for prestigious institutions worldwide. Paradise Genomics, Inc. was established as an outgrowth of GenUs BioSystems to acquire its own clinical data and finalize the validation of new and highly unique biosignatures to market them to medical innovators in the fields of diagnostics, drug discovery, and personalized medicine.
Paradise Genomics focuses on the acquisition of highly qualified clinical samples and the discovery of gene expression signatures from blood and tissues that differentiate health from disease. These qualified and validated disease signatures are being marketed for commercialization to strategic partners with established product and distribution systems. Marketing partners are pharmaceutical companies, biotechnology companies, and medical diagnostic test manufacturers and providers.